In periodontitis, the recurrent bacteria plaque adheres, and intracellular bacteria survival leads to inflammatory immune disorder in periodontal tissue and makes clinical therapeutic outcomes unpredictable. Thoroughly clearing of plaque biofilm and intracellular infectious agents and then regulating the immune environment is a sequential therapy that can match the characteristics of periodontitis. Herein, we construct a near-infrared (NIR)-responsive drug delivery system Hemin@ER-IR808, and investigated its sequential antibacterial and immunomodulatory effects as well as the mechanism in vitro and in vivo. According to the results, NIR laser activated IR808 to produce reactive oxygen species (ROS) to inhibit the proliferation of periodontal bacteria and disrupt the biofilm structure. Then ROS opened the erythrocyte (ER) membrane to release the encapsulated Hemin, which activated the ferroptosis-like stress of intracellular bacteria. Mechanistically, at the early stage of intracellular bacterial infection, Hemin@ER-IR808 ehanced the glycolysis, metabolic reprogramming macrophage to M1-type, which limited the number of intracellular bacteria more than the M2-type; later increased the mitophagy and the level of GPX4, SLC7A11 and HO-1, protecting the macrophage from ferroptosis. In vivo, Hemin@ER-IR808 reduced the number of periodontal flora in rats and alleviated periodontal inflammation. At the later stage, Hemin@ER-IR808 exerted antioxidant effect and promoted the repair of periodontal tissue. In the complex periodontal infectious and inflammatory organizational environment, Hemin@ER-IR808 can emerge as a viable strategy to protect periodontal tissue from reinfection and exert immunomodulatory function to achieve sequential periodontal tissue regeneration.
The regeneration ability of dental pulp stem cells (DPSCs) is essential for vital pulp preservation therapy, but may be disrupted by inflammatory senescence. Mitochondrial dynamics proteins maintain mitochondrial homeostasis and could alleviate inflammatory senescence, though their impact on DPSCs' functions and clinical prognosis remains unclear. Human inflammatory and normal dental pulp were ethically collected from clinic-extracted wisdom teeth to detect inflammation, senescence, mitochondrial dynamics, and oxidative stress markers. The DPSCs' inflammatory senescence model was induced by Escherichia coli lipopolysaccharide, and mitochondrial fusion and fission proteins were modulated with inhibitors to study their relationship with inflammatory senescence. The pulpitis group exhibited inflammatory cell infiltration and overexpressed inflammatory factors, oxidative stress, and senescence markers compared to normal tissue. The same trends were observed in the cell model. Lipopolysaccharide downregulated cell proliferation and differentiation, and upregulated senescence and apoptosis, with decreased OPA1 and increased DRP1. Further reducing fusion exacerbated these phenomena, while reducting fission relieved them. This study highlights the critical role of mitochondrial fusion and fission in DPSCs inflammatory senescence. Enhancing mitochondrial fusion (via OPA1) or suppressing fission (via DRP1) may counteract senescence and restore DPSCs regenerative capacity. These findings provide a potential therapeutic strategy to preserve pulp vitality and improve regenerative outcomes. Maintaining DPSCs functionality is crucial for successful regenerative endodontic treatments. Since inflammation-induced senescence impairs DPSCs regeneration, targeting mitochondrial dynamics - particularly by promoting fusion or inhibiting fission - could enhance pulp tissue repair and long-term tooth preservation. This evidence suggests mitochondrial modulation could be explored for pulpitis management and dental pulp vitality preservation.